Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors

被引：97

作者：

Zakrzewski, Johannes L. ^{[1
]}

Suh, David ^{[1
]}

Markley, John C. ^{[2
]}

Smith, Odette M. ^{[1
]}

King, Christopher ^{[1
]}

Goldberg, Gabrielle L. ^{[1
]}

Jenq, Robert ^{[1
,3
]}

Holland, Amanda M. ^{[1
]}

Grubin, Jeremy ^{[1
]}

Cabrera-Perez, Javier ^{[1
]}

Brentjens, Renier J. ^{[3
]}

Lu, Sydney X. ^{[1
]}

Rizzuto, Gabrielle ^{[1
]}

Sant'Angelo, Derek B. ^{[1
]}

Riviere, Isabelle ^{[2
]}

Sadelain, Michel ^{[2
,3
]}

Heller, Glenn ^{[4
]}

Zuniga-Pflucker, Juan Carlos ^{[5
]}

Lu, Chen ^{[6
]}

van den Brink, Marcel R. M. ^{[1
,3
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA

[2] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol, New York, NY 10021 USA

[3] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA

[4] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA

[5] Univ Toronto, Sunnybrook Res Inst, Dept Immunol, Toronto, ON M4N 3M5, Canada

[6] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA

来源：

NATURE BIOTECHNOLOGY | 2008年 / 26卷 / 04期

关键词：

D O I：

10.1038/nbt1395

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

We present a strategy for adoptive immunotherapy using T-lineage committed lymphoid precursor cells generated by Notch1-based culture. We found that allogeneic T-cell precursors can be transferred to irradiated individuals irrespective of major histocompatibility complex (MHC) disparities and give rise to host-MHC restricted and host-tolerant functional allogeneic T cells, improving survival in irradiated recipients as well as enhancing anti-tumor responses. T-cell precursors transduced to express a chimeric receptor targeting hCD19 resulted in significant additional anti-tumor activity, demonstrating the feasibility of genetic engineering of these cells. We conclude that ex vivo generated MHC-disparate T-cell precursors from any donor can be used universally for 'off-the-shelf' immunotherapy, and can be further enhanced by genetic engineering for targeted immunotherapy.

引用

页码：453 / 461

页数：9

共 55 条

[1]

ABE R, 1991, J IMMUNOL, V147, P739

[2]

ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.immunol.13.1.459

[3] Lymphostromal interactions in thymic development and function [J].

Anderson, G ;

Jenkinson, EJ .

NATURE REVIEWS IMMUNOLOGY, 2001, 1 (01) :31-40

[4] Haematopoietic cell transplantation as immunotherapy [J].

Appelbaum, FR .

NATURE, 2001, 411 (6835) :385-389

[5] THE MHC MOLECULE I-E IS NECESSARY BUT NOT SUFFICIENT FOR THE CLONAL DELETION OF V-BETA-11-BEARING T-CELLS [J].

BILL, J ;

KANAGAWA, O ;

WOODLAND, DL ;

PALMER, E .

JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (04) :1405-1419

[6] INEFFICIENT POSITIVE SELECTION OF T-CELLS DIRECTED BY HEMATOPOIETIC-CELLS [J].

BIX, M ;

RAULET, D .

NATURE, 1992, 359 (6393) :330-333

[7] Dynamics of thymocyte-stromal cell interactions visualized by two-photon microscopy [J].

Bousso, P ;

Bhakta, NR ;

Lewis, RS ;

Robey, E .

SCIENCE, 2002, 296 (5574) :1876-1880

[8] Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 [J].

Brentjens, RJ ;

Latouche, JB ;

Santos, E ;

Marti, F ;

Gong, MC ;

Lyddane, C ;

King, PD ;

Larson, S ;

Weiss, M ;

Rivière, I ;

Sadelain, M .

NATURE MEDICINE, 2003, 9 (03) :279-286

[9] Advances in basic and clinical immunology [J].

Chinen, Javier ;

Finkelman, Fred ;

Shearer, William T. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 118 (02) :489-495

[10] Benign and malignant Epstein-Barr virus-associated B-cell lymphoproliferative diseases [J].

Cohen, JI .

SEMINARS IN HEMATOLOGY, 2003, 40 (02) :116-123

← 1 2 3 4 5 6 →